nejm retatrutide 10mg & 20mg Research Peptide This week's most shared articles:

an effect that has led to FDA approval of several GLP-1 therapies specifically for obesity

How GLP-1 Medications Affect Mood in Bipolar Disorder One of the biggest question marks when it comes to GLP-1s is whether they cause mood changes, critical information for anyone who prioritizes mood stability

Clinical trials and real-world data consistently show: Average weight loss of 1520% on semaglutide or tirzepatide Improvements in blood pressure, cholesterol, and blood sugar Reduced risk of developing type 2 diabetes and cardiovascular disease These outcomes are meaningful both for employee health and long-term cost avoidance

Note that each of these methods carries accuracy and safety risks and manufacturers strongly advise against this due to the risk of inaccurate dosing and medication waste

Seek Urgent or Emergency Care Do not keep treating sulfur burps at home when they occur with: Severe or persistent abdominal pain, especially pain that radiates to the back Repeated vomiting, inability to keep liquids down, fainting, confusion, or very little urine Vomiting blood or material that looks like coffee grounds Black tarry stool, maroon stool, or visible blood A swollen or increasingly painful abdomen with inability to pass stool or gas Chest pressure, shortness of breath, severe weakness, or pain spreading to the arm, jaw, or back High fever, stiff abdomen, severe diarrhea, or rapidly worsening illness People using semaglutide, tirzepatide, or another GLP-1based medicine should take severe abdominal pain, persistent vomiting, major abdominal swelling, inability to hydrate, or inability to pass stool or gas seriously

What is new is the change in the obesity and weight loss landscape brought on by the GLP-1 revolution